To assess the physiological role of PNPLA3 on lipid-induced hepatic steatosis and insulin resistance, we fed rats a high-fat diet and decreased hepatic and adipose pnpla3 expression by pnpla3 ASO treatment for 1 month. The gene discussed is PNPLA3; the disease is fatty liver disease.